, World cancer report, 2014.
Clinical nutrition guidelines of the French Speaking Society of Clinical Nutrition and Metabolism (SFNEP): summary of recommendations for adults undergoing non-surgical anticancer treatment, Dig Liver Dis, 2014. ,
Obesity as a major risk factor for cancer, J Obes, p.291546, 2013. ,
Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients, Breast Cancer Res Treat, vol.146, pp.183-188, 2014. ,
Breast cancer outcomes in a population with high prevalence of obesity, J Surg Res, vol.198, pp.371-376, 2015. ,
Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support, Int J Breast Cancer, pp.1-8, 2011. ,
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies, Ann Oncol, vol.25, pp.1901-1914, 2014. ,
Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38, Cancer Epidemiol Prev Biomark, vol.25, pp.51-59, 2016. ,
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy, Breast Cancer Res Treat, vol.159, pp.79-86, 2016. ,
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, vol.9, pp.629-635, 2008. ,
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography, J Appl Physiol Bethesda Md, vol.85, pp.115-122, 1998. ,
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients, J Cachex Sarcopenia Muscle, vol.7, pp.458-466, 2016. ,
Sarcopenic obesity: a probable risk factor for dose limiting toxicity during neoadjuvant chemotherapy in oesophageal cancer patients, Clin Nutr, vol.35, 2016. ,
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer, 2013. ,
, Curr Opin Support Palliat Care, vol.7, pp.383-389
Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases, HPB, vol.17, pp.438-446, 2015. ,
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol Off J Am Soc Clin Oncol, vol.31, pp.1539-1547, 2013. ,
Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review, Eur J Cancer Oxf Engl, vol.57, pp.58-67, 2016. ,
The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer, Oncologist, vol.17, pp.1240-1245, 2012. ,
Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study, J Cancer Surviv, vol.6, pp.398-406, 2012. ,
Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients, Breast Cancer Res Treat, vol.144, pp.143-152, 2014. ,
Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients, Cancer Med, vol.5, pp.41-48, 2016. ,
High subcutaneous adipose tissue predicts the prognosis in metastatic castrationresistant prostate cancer patients in post chemotherapy setting, 2015. ,
, Eur J Cancer Oxf Engl, vol.51, pp.2570-2577
Cancer du sein infiltrant non métastatique-questions d'actualités (synthèse) 82, 2012. ,
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image, J Appl Physiol Bethesda Md, vol.97, pp.2333-2338, 2004. ,
Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane based chemotherapy, Clin Cancer Res Clincanres, 2016. ,
Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer, Gut, vol.59, pp.341-347, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00476649
Visceral obesity may affect oncologic outcome in patients with colorectal cancer, Ann Surg Oncol, vol.15, pp.1918-1922, 2008. ,
Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome, Insights Imaging, vol.6, pp.489-497, 2015. ,
Quantification of the visceral and subcutaneous fat by computed tomography: interobserver correlation of a single slice technique, Diagn Interv Imaging, vol.94, pp.879-884, 2013. ,
Sarcopenia: European consensus on definition and diagnosis report of the European working group on sarcopenia in older people, Age Ageing, vol.39, pp.412-423, 2010. ,
5: impact of a structured physical activity program and nutritional supplementation on regional body composition: results from the Vitality, Independence, and Vigor in the Elderly 2 Study (VIVE2), Clin Nutr, vol.35, pp.30294-30295, 2016. ,
Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability, J Am Geriatr Soc, vol.50, pp.889-896, 2002. ,
Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer, J Cachexia Sarcopenia Muscle, 2016. ,
Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites, J Korean Med Sci, vol.29, pp.1253-1259, 2014. ,
New criteria for Bobesity disease^ in Japan: the Examination Committee of Criteria for BObesity Disease^ in Japan, Japan Society for the Study of Obesity, Circ J Off J Jpn Circ Soc, vol.66, pp.987-992, 2002. ,
Visceral adiposity and cancer survival: a review of imaging studies, Eur J Cancer Care (Engl, 2016. ,